Skip to main content

Kepler Capital Reaffirms Their Buy Rating on Bayer (0P6S)

Tipranks - Tipranks - Fri Mar 6, 7:50PM CST

Kepler Capital analyst Christian Faitz maintained a Buy rating on Bayer on March 4 and set a price target of €53.00. The company’s shares closed last Wednesday at €37.40.

Claim 70% Off TipRanks Premium

According to TipRanks, Faitz is a 4-star analyst with an average return of 6.0% and a 50.56% success rate. Faitz covers the Basic Materials sector, focusing on stocks such as AlzChem Group AG, K+S Aktiengesellschaft, and Yara International.

In addition to Kepler Capital , Bayer also received a Buy from Goldman Sachs’s James Quigley in a report issued on March 4. However, yesterday, Deutsche Bank maintained a Hold rating on Bayer (LSE: 0P6S).

See today’s best-performing stocks on TipRanks >>

Based on Bayer’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of €9.66 billion and a GAAP net loss of €963 million. In comparison, last year the company earned a revenue of €9.97 billion and had a GAAP net loss of €4.18 billion

Read More on GB:0P6S:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).